April 20, 2024
Stocks & Bonds
[STOCK WATCH] Samjin Pharmaceutical falls 1.74%
[THE INVESTOR] As of Oct. 27 02:25 P.M., Samjin Pharmaceutical declined 1.74%, compared with yesterday, to 33,850 won. It had increased 3.36% through the past month. Standard deviation, the variableness index, was 1.4% over the same period over one month.
Compared with its close competitors within the same industry, KOSPI, the monthly earnings rate of Samjin Pharmaceutical was proper, while its volatility was the lowest. Over the recent month, the return-on-risk, the return on investment with consideration about risk, was 2.4. Though the volatility was the lowest, the return-on-risk recorded a poor value because the return was not so high. However, compared with the KOSPI industry, the return-on-risk is below the industrial mean, 5.6, and thus it is hard to say that the industrial comparison performance was positive.
By HeRo (hero@heraldcorp.com)
This article is produced by the algorithm developed by the artificial intelligence developer ThinkPool in collaboration with Herald Corp.
Compared with its close competitors within the same industry, KOSPI, the monthly earnings rate of Samjin Pharmaceutical was proper, while its volatility was the lowest. Over the recent month, the return-on-risk, the return on investment with consideration about risk, was 2.4. Though the volatility was the lowest, the return-on-risk recorded a poor value because the return was not so high. However, compared with the KOSPI industry, the return-on-risk is below the industrial mean, 5.6, and thus it is hard to say that the industrial comparison performance was positive.
By HeRo (hero@heraldcorp.com)
This article is produced by the algorithm developed by the artificial intelligence developer ThinkPool in collaboration with Herald Corp.
